Isturisa

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 55292-321
  • Package NDC 55292-321-20
  • Package NDC 55292-321-60
  • Application number NDA212801
  • SPL ID 5c1e5bfa-9d7b-4a4a-b030-caf7bb57c6df
  • SPL set ID f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2
  • UNII Y6581YAW9V
  • RxCUI 2286275
  • RxCUI 2286281
  • RxCUI 2286283
  • RxCUI 2286285
  • RxCUI 2286288
  • RxCUI 2286290

What the source publishes

Labeler
Recordati Rare Diseases, Inc.
Active ingredients
OSILODROSTAT
Form
TABLET, COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:55292-321_5c1e5bfa-9d7b-4a4a-b030-caf7bb57c6df
{
  "name": "Isturisa",
  "splId": "5c1e5bfa-9d7b-4a4a-b030-caf7bb57c6df",
  "labels": [
    {
      "setId": "f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Recordati Rare Diseases, Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "20 TABLET, COATED in 1 BLISTER PACK (55292-321-20)",
      "package_ndc": "55292-321-20",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20291231",
      "marketing_start_date": "20200331"
    },
    {
      "sample": false,
      "description": "60 TABLET, COATED in 1 BLISTER PACK (55292-321-60)",
      "package_ndc": "55292-321-60",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20291231",
      "marketing_start_date": "20200331"
    }
  ],
  "productId": "55292-321_5c1e5bfa-9d7b-4a4a-b030-caf7bb57c6df",
  "useDomain": "unknown",
  "dosageForm": "TABLET, COATED",
  "productNdc": "55292-321",
  "deaSchedule": null,
  "genericName": "OSILODROSTAT",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20291231",
  "activeIngredients": [
    {
      "name": "OSILODROSTAT PHOSPHATE",
      "strength": "5 mg/1"
    }
  ],
  "applicationNumber": "NDA212801",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20200331",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "Y6581YAW9V"
    ],
    "rxcui": [
      "2286275",
      "2286281",
      "2286283",
      "2286285",
      "2286288",
      "2286290"
    ],
    "spl_set_id": [
      "f3a5ec24-63c3-4d83-b1c0-6c550fbe7ae2"
    ],
    "manufacturer_name": [
      "Recordati Rare Diseases, Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:55292-321_5c1e5bfa-9d7b-4a4a-b030-caf7bb57c6df"